Article
Chronic kidney disease epidemic: myth and reality.
Section of Nephrology, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Internal and Emergency Medicine (impact factor:
2.06).
10/2011;
6 Suppl 1:69-76.
DOI:10.1007/s11739-011-0686-4
pp.69-76
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.
[show abstract] [hide abstract]
ABSTRACT: Nowadays kidney transplantation and dialysis are the only available therapies for end-stage renal disease management. They imply a considerable increase in plasma concentration of uremic wastes including creatinine, urea and uric acid. These invasive procedures impose high social costs that prevent many low-income countries from adequately treating the patients affected by renal insufficiency. For years, many studies on uremic waste removal through the gut lumen have been published with conflicting results. More recently, microencapsulation of probiotic bacteria has been performed by different research groups. This evidence has opened a new perspective on therapeutic modification of gut bacterial flora in the context of renal disease. This review gives an overview of the experimental and clinical use of probiotic formulations in the context of end-stage renal disease.International Urology and Nephrology 04/2013; · 1.47 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
calculate glomerular filtration rate
cardiovascular disease
cardiovascular outcomes
chronic kidney disease
clinical risk conditions
common causes
Considerable interest
considerations point
declines
elderly population
Kidney Disease Outcomes Quality Initiative
kidney dysfunction
major public health problem
major role
multi-dimensional approach
plan strategies
Renal Disease formula
renal function
stage 3 CKD
substantial proportion